Strategic choices facing the pharmaceutical industry: A case for innovation

The pharmaceutical industry was founded at a time of unusual scientific, political and economic opportunity, but now the industry finds itself facing important choices in a difficult economic and regulatory environment. Only those companies capable of improving the productivity of their R&D departments can remain important players in the future. The author discusses the different approaches to innovation that are available to the leading pharmaceutical companies and argues for the 'offensive' strategy.